CYTOSORBENTS CORPORATION (CTSO) Operating income 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual operating income history from SEC filings — each fiscal year as reported.
-$14.7MFY2025 · since FY2016: -$11.5M → -$14.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.7M | +10.4% |
| FY2024 | -$16.5M | +48.5% |
| FY2023 | -$31.9M | -1.4% |
| FY2022 | -$31.5M | -38.6% |
| FY2021 | -$22.7M | -119.3% |
| FY2020 | -$10.4M | +45.3% |
| FY2019 | -$19.0M | -21.7% |
| FY2018 | -$15.6M | -58.3% |
| FY2017 | -$9.8M | +14.4% |
| FY2016 | -$11.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice